10x Genomics, Inc. (TXG) — 8-K Filings

8-K Filings (14)

• 10x Genomics Reports Director/Officer Changes — Nov 14, 2025 Risk: low
  10x Genomics, Inc. filed an 8-K on November 14, 2025, reporting events as of November 12, 2025. The filing covers the departure of directors or certain officers
• 8-K Filing — Nov 6, 2025
• 10x Genomics Files 8-K on Financials — Aug 7, 2025 Risk: low
  On August 7, 2025, 10x Genomics, Inc. filed an 8-K report. The filing primarily concerns the company's results of operations and financial condition, as well as
• 10x Genomics Holds Annual Stockholder Meeting — Jun 5, 2025 Risk: low
  On June 3, 2025, 10x Genomics, Inc. filed an 8-K report to announce the results of its annual meeting of stockholders. The company's stockholders voted on sever
• 10x Genomics Files 8-K Report — May 14, 2025 Risk: low
  On May 12, 2025, 10x Genomics, Inc. filed an 8-K report. The filing indicates the company's principal executive offices are located at 6230 Stoneridge Mall Road
• 10x Genomics Files 8-K with Financial Updates — May 8, 2025 Risk: medium
  On May 6, 2025, 10x Genomics, Inc. filed an 8-K report detailing significant financial and operational updates. The filing includes information on the company's
• 10x Genomics Files 8-K on Financials — Feb 12, 2025 Risk: low
  On February 12, 2025, 10x Genomics, Inc. filed an 8-K report. The filing primarily concerns the company's results of operations and financial condition, as well
• 10x Genomics Files 8-K on Financials — Jan 13, 2025 Risk: low
  On January 12, 2025, 10x Genomics, Inc. filed an 8-K report. The filing primarily concerns the company's results of operations and financial condition, as well
• 10x Genomics Files 8-K on Financials — Oct 9, 2024 Risk: low
  On October 9, 2024, 10x Genomics, Inc. filed an 8-K report. The filing primarily concerns the company's results of operations and financial condition, as well a
• 10x Genomics Board & Exec Comp Changes — Jul 11, 2024 Risk: medium
  On July 10, 2024, 10x Genomics, Inc. announced changes to its board of directors and executive compensation. Specifically, Dr. David R. Walt has been appointed
• 10x Genomics Elects New Directors, Adjusts Executive Pay — Jun 20, 2024 Risk: medium
  10x Genomics, Inc. announced on June 18, 2024, changes to its board of directors and executive compensation. Specifically, the company elected two new directors
• 10x Genomics Holds Annual Meeting, Votes on Directors and Auditors — Jun 13, 2024 Risk: low
  On June 11, 2024, 10x Genomics, Inc. filed an 8-K report to announce the results of its 2024 Annual Meeting of Stockholders, which took place on June 11, 2024.
• 10x Genomics Files 8-K on Officer/Director Changes — Jan 16, 2024
  10x Genomics, Inc. filed an 8-K on January 16, 2024, reporting an event that occurred on January 15, 2024. This filing indicates changes related to the departur
• 10x Genomics Files 8-K on Operations & Financial Condition — Jan 8, 2024
  10x Genomics, Inc. filed an 8-K on January 8, 2024, to report on its results of operations and financial condition. This filing, under SEC File Number 001-39035

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX